公司背景介绍公司是一家综合性制药企业，集研发、生产和销售于一体，拥有创新药物的研发管线。公司的产品组合和管线覆盖中国最大、增长最快的治疗领域，包括消化系统、心血管、内分泌、神经系统疾病和炎症疾病。公司在研管线公司创新药物管线专注于多种适应症的在研药物，包括一款肿瘤药物、一款可能用于治疗湿性年龄相关性黄斑变性（wAMD）、糖尿病性黄斑水肿（DME）和视网膜静脉阻塞（RVO）的首款口服药物，以及另外...
Source Link公司背景介绍公司是一家综合性制药企业，集研发、生产和销售于一体，拥有创新药物的研发管线。公司的产品组合和管线覆盖中国最大、增长最快的治疗领域，包括消化系统、心血管、内分泌、神经系统疾病和炎症疾病。公司在研管线公司创新药物管线专注于多种适应症的在研药物，包括一款肿瘤药物、一款可能用于治疗湿性年龄相关性黄斑变性（wAMD）、糖尿病性黄斑水肿（DME）和视网膜静脉阻塞（RVO）的首款口服药物，以及另外...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.